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Abstract: Perseverative cognitions such as rumination and worry are key components of 
mental illnesses such as depression and anxiety. Given the frequent comorbidity of conditions in 
which rumination and worry are present, it is possible they are underpinned by the same 
cognitive process. Furthermore, rumination and worry appear to be part of a causal chain that 
can lead to long-term health consequences, including cardiovascular disease and other chronic 
conditions. It is important therefore to understand what interventions may be useful in reducing 
their incidence. This systematic review aimed to assess treatments used to reduce worry and/or 
rumination. As we were interested in understanding the current treatment landscape, we limited 
our search from 2002-2012. Nineteen studies were included in the review and were assessed 
for methodological quality and treatment integrity. Results suggested that mindfulness-based 
and cognitive behavioural interventions may be effective in the reduction of both rumination and 
worry; with both Internet-delivered and face-to-face delivered formats useful. More broadly, it 
appears that treatments in which participants are encouraged to change their thinking style, or 
to disengage from emotional response to rumination and/or worry (e.g., through mindful 
techniques), could be helpful. Implications for treatment and avenues for future research are 
discussed. 
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INTRODUCTION 
The aim of this systematic review was to assess treatments used to reduce rumination and/or 
worry. 
 
The definition of rumination and worry 
There are many definitions of worry and rumination. The most often used definition of worry 
suggests that it constitutes a chain of thoughts and images that are affectively negative and 
relatively uncontrollable (Borkovec, Robinson, Pruzinsky, & DePree, 1983; Borkovec, Ray, & 
Stober, 1998). Descriptively, worry is dominated by negatively valenced thought activity, most 
often about negative events we are afraid will occur in the future (Borkovec et al., 1998). 
However, although worry is often associated with negative effects, it may also have some value. 
For example, day-to-day worries may function to motivate the individual to deal with a perceived 
threat that is causing worry (Davey, 1993); and many of these daily worries appear to be related 
to problem-solving. For example, in a study by Szabo & Lovibond (2002) students were asked 
to self-monitor and record worry-related thoughts when they worried at least a little. These 
reported thoughts were then categorised by independent raters and over half of the thoughts 
involved problem solving; e.g., worrying about how to resolve a dispute with a friend, break up 
with a respective other, or make a plan for the coming day/s. The other half were more 
stereotypically worry-related thoughts such as anticipating bad outcomes or self-blame for 
events or situations that had not turned out as planned. Therefore, worry could be a constructive 
process (if the process results in a solution to a perceived problem) or a non-constructive 
process (if not focussed on solving a problem; or if an appropriate solution cannot be arrived at).  
 
When it comes to rumination, there are many different definitions, all of which share the 
common experience of repetitive, intrusive, negative cognitions (see Papageorgiou & Siegle, 
2003). Some of these definitions are narrow. For example, Nolen-Hoeksema's (1991) well-
known definition of depressive rumination suggests that the focus of rumination is on one's own 
depressive symptoms. Other definitions are very broad. For example, Martin & Tesser (1996), in 
their self-regulation model of ruminative thought, define rumination in the context of thinking 
about one's own goals, suggesting that this thinking may occur in the absence of immediate 
environmental cues. According to Martin & Tesser (1996) there are three mechanisms by which 
ruminative thinking can be stopped: distraction, disengagement from the goal, and goal 
attainment. 
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The link between rumination and worry 
Recurrent negative thinking or thought is a primary component of mood-related emotional 
disorders. Research regarding rumination and/or worry has been dominated by clinical/health 
psychology, with rumination and worry thought to be implicated in the aetiology of a number of 
psychological disorders, e.g., depression and anxiety (Lyubomirsky, Caldwall, & Nolen-
Hoeksema, 1998; Mellings & Alden, 2000), and associated with increased physical symptom 
reporting (Hazlett & Haynes, 1992), intrusive off-task thoughts (Sarason, Pierce, & Sarason, 
1996), negative self-evaluations, diminished feelings of control and feelings of helplessness 
(Lyubomirsky, Kasri, & Zehm, 2003). Furthermore, laboratory studies have shown prolonged 
physiological arousal and delayed recovery in individuals who ruminate or who are asked to 
recall stressful events (Glynn, Christenfeld, & Gerin, 2002; Ironson et al., 1992; Lampert, Jain, 
Burg, Batsford, & McPherson, 2000; Roger & Jamieson, 1988).  
 
Barlow & DiNardo (1991) proposed that worry is “fundamentally a presenting characteristic of all 
anxiety disorders with the possible exception of simple phobia” (p. 115); and worry also occurs 
frequently in major depression (Chelminski & Zimmerman, 2003). Although studies tend to 
examine worry in relation to anxiety and rumination in relation to depression, a few studies have 
looked at the effects of both of these forms of repetitive thinking. For example, Segerstrom, 
Tsao, Alden, & Craske (2000) examined the effects of these processes concurrently and found 
that repetitive thought of either kind was related to both anxious and depressed symptoms. 
More recently, McLaughlin, Borkovec & Sibrava (2007) induced worry and rumination in a 
student sample to assess whether or not they affected mood in the same, or different, ways. 
They found that worry and rumination were both associated with increases in anxiety, 
depression and negative affect, and with decreases in positive affect. Interestingly, their 
analysis also indicated that shifting from worry to rumination resulted in decreased anxiety and 
increased depression; and shifting from rumination to worry created an opposing pattern.  
 
Therefore, when the two forms of thinking occur sequentially, it appears worry is associated with 
predominantly anxious affect, and rumination is associated with predominantly depressive 
affect. As such, both processes appear to lead to the generation of negative mood states; with 
the different outcomes reflective of the focus or content of rumination or worry respectively. 
These findings are further supported by the results of prior studies conducted separately on 
worry and rumination. For example, Segerstrom, Stanton, Alden, & Shortridge (2003) found that 
negative affectivity is generated by negative thinking of any type; Chelminski & Zimmerman 
 5 
 
(2003) found that worry occurs in depression; and Nolen-Hoeksema (2000) found that 
rumination predicts the onset of anxiety. These findings suggest a shared component to these 
forms of repetitive thinking and a considerable research base supports this showing that anxiety 
and depression are frequently comorbid (Brown & Barlow, 1992; Brown, Campbell, Lehman, 
Grisham, & Mancill, 2001; Kessler et al., 1994; Kessler, Sonnega, Bromet, Hughes, & Nelson, 
1995; Kessler et al., 1998). This comorbidity may be explained in a number of ways: firstly, it is 
possible that having one disorder increases the risk of developing another; alternatively, it is 
possible that anxiety and mood disorders may develop from the same underlying predisposition 
(Barlow, 2002).  
 
In line with the notion that these disorders may develop from the same underlying 
predisposition, one possibility is that both of these disorders are underpinned by a similar 
cognitive process. For Brosschot, Gerin & Thayer (2006) rumination and worry represent 
different but related manifestations of the same underlying cognitive process. The difference in 
these constructs is reflected in a different focus of “content” (e.g., future focussed in worry; past 
focussed in rumination); however, they are purported to share an underlying cognitive process 
which maintains psychophysiological arousal. This process is labelled ‘perseverative cognition’ 
and is defined as: “the repeated or chronic activation of the cognitive representation of one or 
more psychological stressors” (Brosschot et al., 2006, p.114). Our unique ability as humans 
means that we can look back and learn from the past, and we can look ahead to plan for the 
future; however, this may also lead to ‘ruminating’ about the past, or ‘worrying’ about the future 
(Brosschot, Verkuil & Thayer, 2010). While psychological stressors themselves do not involve 
direct physical danger, they are composed of perceived threats to the physical or psychological 
integrity of the individual (Broschott et al., 2010). It is these cognitive representations, or 
thoughts, that result in a “fight-or-flight” response (Frijda, 1988), which is followed by a casade 
of biological and physiological changes in the body. These changes begin in the brain and 
cause peripheral responses to stress such as increased heart rate and blood pressure; and 
higher levels of stress hormones such as cortisol (Lovallo, 2004).  
 
Evidence in the literature suggests that perseverative cognition (e.g., rumination and worry) in 
addition to having direct physiological effects, also mediates the prolonged effects of stressors. 
Some researchers have considered the relationship between rumination/worry and somatic 
disease or somatic complaints; with suggestive evidence for a prospective relationship. For 
example, Brosschot & van den Doef (2006) reported that a total of 1 week's worry duration was 
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prospectively related to health complaints in high school and college students. Trait rumination 
has been prospectively related to self-reported physical health issues one year later (Thomsen 
et al., 2004); and cross-sectional relationships have been found between trait rumination and 
health complaints (Lok & Bishop 1999) and between frequency of worry about conflicting goals 
and somatisation (Emmons & King, 1988). Furthermore, with regards to verifiable disease 
outcome, a tendency to worry has been shown to predict a second myocardial infarction 
(Kubzansky et al., 1997).  
 
Other researchers have considered the relationship between worry/rumination and endocrine, 
neuroendocrine and physiological responses (e.g. cardiac activity; blood pressure). Chronic 
activation of the hypothalamic-pituitary-adrenal axis (predominantly cortisol release) is purported 
to increase an individual's susceptibility to many disease states. This is thought to be due to 
suppression of the immune system which has multiple pathological effects, e.g., dysregulation 
of metabolism and hippocampal degeneration (Brosschot et al., 2006). Several studies have 
shown that rumination and worry are associated with abnormal immune responses and elevated 
levels of cortisol. For example, trait rumination has been associated with higher morning salivary 
cortisol (Schlotz, Hellhammer, Schulz, & Stone, 2004); and a higher number of several types of 
luekocytes (white blood cells of the immune system involved in defending the body against 
disease; Thomsen et al., 2004). Other studies have reported that participants reporting high 
levels of trait worry had fewer natural killer (NK) cells (Segerstrom, Solomon, Kemeny & Fahey, 
1998); and that high trait worry was related to suppression of an expected increase in NK cells 
when exposed to fear-evoking situations (Segerstrom, Glover, Craske & Fahey, 1999).  
 
People with chronically elevated heart rates (HR), and reduced heart rate variability (HRV; an 
indicator of parasympathetic activity), are at increased risk for all-cause mortality (Palatini & 
Julius, 1997); and reduced HRV has also been associated with increased risk of developing 
hypertension and other cardiovascular disorders (Thayer & Friedman, 2004; Stein & 
Kleiger,1999). A sustained level of high blood pressure (BP) is also a risk factor for many 
diseases including cardiovascular disease (CVD) and diabetes (Schwartz et al., 2003). 
Researchers have shown that both dispositional measures of, and experimentally induced, 
worry are associated with low HRV and high HR (Lyonfields, Borkovec & Thayer, 1995; Thayer, 
Friedman & Borkovec, 1996). Furthermore, trait rumination has been associated with slower HR 
recovery after cognitive stress tasks (Roger & Jamieson, 1988); and state, but not trait, worry 
has been related to high HR (Dua & King, 1987). Elevated BP has also been associated with 
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anticipation before emotional events in several studies; e.g., in students anticipating oral 
defence of their PhD (van Doornen & van Blokland, 1992), prior to dental treatment (Brand et 
al., 1995), and mental arithmetic (Contrada, Wright & Glass, 1984). In addition, multiple studies 
showed that emotional reactivity (which is strongly related to worry and rumination) was 
positively related to resting BP (Melamed, 1987), ambulatory BP (Melamed, 1996), and to high 
risk levels of lipids (fats) in blood plasma (Melamed, 1994).  
 
Taken together, these findings appear to suggest that perseverative cognition (e.g., rumination, 
worry) is associated with decreased parasympathetic activity and increased sympathetic 
nervous system activity (Brosschott et al., 2006). Decreased parasympathetic activity suggests 
that rumination or worry are likely and independent risk factors for CVD; furthermore, low 
parasympathetic activity has also been found to characterise depression and anxiety disorders 
(Lyonfields et al., 1995; Thayer et al., 1996; Friedman & Thayer, 1998; Friedman et al., 1993). 
Interestingly, depression and anxiety are increasingly documented as important risk factors for 
cardiovascular and other disorders (e.g., Kawachi et al., 1994; Wulsin, Vaillant & Wells, 1999). 
Therefore it is possible that worry and rumination may serve as mediators of the relationship 
between anxiety and depression with CVD (Brosschot et al., 2006). 
 
Another possibility is that anxiety and depression are underpinned by a shared mood trait such 
as negative affect (McLaughlin et al., 2007). Watson, Clark, & Tellegen (1988) characterise 
negative affect (NA) as a general dimension of subjective distress and "unpleasurable 
engagement that subsumes a variety of aversive mood states" (p.1063); e.g., fear, 
nervousness, guilt, contempt, anger, disgust. Trait NA has been shown to roughly correspond to 
the personality factor anxiety/neuroticism; and Tellegen has also suggested that high levels of 
NA (both state and trait) are major distinguishing features of depression and anxiety, 
respectively (Tellegen, 1985). McLaughlin et al. (2007) suggest that this is the shared 
underlying factor which fosters rumination and/or worry. The positions of Brosschot et al. (2006) 
and McLaughlin et al. (2007) are compatible in as much as a predisposition to engage in 
perseverative cognition with a negative focus may potentially be causal in the development of 
anxiety and/or depression. Worry and rumination appear to worsen, not resolve, negative 
emotional states (Morrow & Nolen-Hoeksema, 1990; Nolen-Hoeksema & Morrow, 1993); 
furthermore, both forms of perseverative cognition are associated with over-general memory 
and a high level of abstract as opposed to concrete processing (e.g., Watkins & Teasdale, 2001; 
Williams, 1996).  
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In a comprehensive review, Brosscot et al. (2006) suggested that perseverative cognition (e.g., 
rumination, worry) may be part of a causal chain that can lead to long-term health 
consequences, including cardiovascular disease and other chronic conditions and illnesses. A 
position that appears to be supported by the research presented above. Given the prevalence of 
perseverative cognition (e.g., rumination, worry) in the aetiology of different illnesses and 
conditions, it is important to understand what interventions may be useful in reducing the 
incidence of rumination and/or worry.  
 
Objectives 
The objective of this systematic review was to assess treatments used to reduce rumination 
and/or worry. 
 
Criteria for inclusion/exclusion 
Study aims and design 
An initial review of the literature highlighted that there were very few studies explicitly designed 
to target rumination or worry. Therefore we expanded our inclusion criteria such that studies had 
to either: 1. explicitly treat rumination/worry; or 2. include secondary measures for the effects of 
treatment on rumination/worry. Studies in which rumination or worry was measured, but where 
they were only tested as mediators/moderators for changes in other study variables, were not 
included. The following study designs were eligible for inclusion: randomised controlled trials 
(RCT); randomised clinical controlled trials; clinical controlled trials; waitlist controlled trials; 
randomised trials; cohort studies; quasi-experimental studies.  
 
Study status 
Only articles from peer reviewed journals (January, 2002 – Dec, 2012) and written in English 
were eligible for inclusion. We limited our search to research published from 2002 to 2012 
because we were interested in understanding the current landscape with regards to treatments 
utilised in the reduction of rumination and/or worry.  
 
Participants 
This review considered studies of adults (>18 years of age) only. We included studies where 
participants were drawn from both clinical and non-clinical (e.g., general population, students) 
populations. Studies including participants with depression, anxiety (or a specific anxiety 
disorder, e.g., social phobia, generalised anxiety disorder, etc.) or a mixture of depression and 
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anxiety were eligible for inclusion in the review. Studies including participants with learning 
disabilities or severe mental disorder (e.g., schizophrenia, bipolar disorder, depression with 
psychotic symptoms, psychosis, serious suicidal thoughts) or alcohol or substance abuse were 
not eligible for inclusion.  
 
Types of outcome measures 
Studies were eligible for inclusion if they utilised primary or secondary measures for rumination 
and/or worry: e.g., Ruminative Response Scale (RRS; Nolen-Hoeksema, 1991), or equivalent; 
Penn State Worry Questionnaire (PSWQ; Meyer, Miller, Metzger, & Borkovec, 1990), or 
equivalent. 
 
Search strategy for identification of studies 
The following electronic databases were examined in December, 2012: PsycINFO; 
PsycARTICLES; Medline; the Cochrane Library database of systematic reviews; and the Centre 
for Reviews and Dissemination (CRD) database.  
 
The search in PsycInfo, PsycARTICLES and Medline made use of the following search terms: 1 
Rumination; 2 Ruminat* AND thought(s) OR thinking; 3 Perseverative AND thought(s) OR 
thinking; 4 Repetitive AND thought(s) OR thinking; 5 Intrusive AND thought(s) OR thinking; 6 
Negative AND thought(s) OR thinking; 7 Worry; 8 Worry AND thought(s) or thinking; 9 Anxi*; 10 
Anxi* AND thought(s) OR thinking; 11 Stress AND thought(s) OR thinking; 12 Depress* AND 
thought(s) OR thinking; 13 #1 OR #2 OR #3 OR #4 OR #5 OR #6 OR #7 OR #8 OR #9 OR #10 
OR #11 OR #12 AND “intervention” OR “randomis(z)ed controlled trial” OR “RCT” OR 
“Controlled trial” OR “Waitlist controlled trial” OR “Randomis(z)ed trial” OR “Cohort” OR “Quasi-
experimental”. The search in CRD and Cochrane Library databases made use of the following 
terms: 1 Rumination; 2 Perseverative AND thought(s) OR thinking; 3 Repetitive AND thought(s) 
OR thinking; 4 Intrusive AND thought(s) OR thinking; 5 Negative AND automatic thought(s) OR 
thinking; 6 Worry; 7 Stress; 8 Depression AND thought(s) OR thinking.  
 
Brackets indicate where search terms were entered twice with the different spellings. Search 
terms were selected based on common key terms identified during an initial search of the 
literature and related reviews.  
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METHODS 
The authors screened abstracts and titles of articles against the inclusion criteria and full text 
versions of potentially relevant articles were obtained for more detailed analysis. In total, 108 
articles were obtained and reviewed. Of these, 89 were excluded from this review for the 
following reasons: not intervention study, no measure of rumination or worry (or 
rumination/worry measured but direct effects not reported), sample not adults, participants 
inappropriate, duplicate data (outcomes reported elsewhere), and sample too small (e.g., case 
studies). The remaining 19 articles were included in this review (see Appendix A for the full 
reference list). Figure 1 shows a summary of study selection and exclusion. 
 
Figure 1: Flow chart of study selection 
[Include Figure 1 about here] 
 
Description of included studies 
The search of the databases resulted in 19 articles meeting the inclusion criteria (N=1778). The 
majority of studies were described as randomised controlled trials (RCT; N=15); two were 
studies described as waitlist controlled designs (WLC), and two studies were described as 
randomised designs (with no control group). Seven studies drew their participants from clinical 
environments (e.g., hospitals; GP practices); four studies utilized students; and eight studies 
were run with participants recruited from the general population. Measures of rumination and/or 
worry were included in the majority of studies as secondary measures. However, one study 
(Watkins et al., 2011) tested an intervention specifically designed to reduce rumination; and 
other studies stipulated that measuring change in rumination and/or worry was a primary aim 
(Andersson et al., 2012; Campbell, Labelle, Bacon, Faris, & Carlson, 2012; Ekkers et al., 2011; 
Jain et al., 2007; Wolitzky-Taylor & Telch, 2010). Most studies assessed change in either worry 
(N=9) or rumination (N=8), however two studies (Robins, Keng, Ekblad, & Brantley, 2012; van 
Aalderen et al., 2012) assessed change in worry and rumination.  
 
The majority of studies (N=14) assessed treatments that were delivered face-to-face either in 
group format or one-to-one; however, five studies assessed Internet-based interventions. Four 
of these studies assessed Internet-based cognitive behaviour therapy (iCBT) against other 
internet-based treatments (Andersson et al., 2012; Paxling et al., 2011; Robinson et al., 2010; 
Titov, Andrews, Johnston, Robinson, & Spence, 2010); whilst the other study assessed a web 
tool (My Disaster Recovery website) which was developed specifically for survivors of Hurricane 
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Ike in the USA (Steinmetz, Benight, Bishop, & James, 2012), against an information only 
website. Andersson et al. (2012) compared iCBT with Internet-based psychodynamic treatment 
(iPDT) in participants with generalised anxiety disorder (GAD); Paxling et al. (2011) assessed 
the efficacy of iCBT against a waitlist control condition for participants with GAD; Robinson et al. 
(2010) compared the efficacy of clinician assisted iCBT to technician assisted iCBT in 
participants with GAD; and Titov et al. (2010) compared the efficacy of iCBT against a waitlist 
control condition for a mixed sample of anxiety disorders (GAD, social anxiety disorder [SAD], 
and panic disorder [PD]). Details of included studies can be seen in Table 1. 
 
[Insert Table 1 about here] 
 
In the case of interventions delivered face-to-face, three studies compared CBT-based 
interventions against either waitlist control conditions or other interventions. Leichsenring et al. 
(2009) compared the efficacy of CBT against short-term psychodynamic psychotherapy for 
participants with GAD; Watkins et al. (2011) compared rumination-focussed CBT plus treatment 
as usual against treatment as usual alone in participants with depression; and Westra, Arkowitz, 
& Dozois (2009) assessed the effect of adding motivational interviewing techniques to CBT for 
participants with GAD. Seven studies assessed mindfulness-based interventions against either 
waitlist control conditions or other treatments. Out of these seven studies, four studies assessed 
the efficacy of mindfulness-based stress reduction (MBSR). Campbell et al. (2012) assessed 
the effect of participation in MBSR on attention, rumination and resting blood pressure in female 
cancer patients; Robins et al. (2012) assessed the effect of participation in MBSR on emotional 
experience and expression; Shapiro, Oman, Thoresen, Plante, & Flinders (2008) compared 
MBSR against another meditation-based relaxation programme - Easwaran’s Eight Point 
Programme (EPP) – for change in mindfulness; and Vollestad, Sivertsen, & Nielsen (2011) 
assessed the efficacy of MBSR in the treatment of anxiety. The remaining three studies 
assessed other mindfulness-based treatments. Specifically, Feldman, Greeson, & Senville 
(2010) compared mindful-breathing, progressive muscle relaxation, and loving-kindness 
meditation for effect on negative reactions to repetitive thoughts; Jain et al. (2007) compared 
mindful-meditation to relaxation training for their effects on distress, positive states of mind, 
rumination and distraction; and van Aalderen et al. (2012) assessed mindfulness-based 
cognitive therapy for the treatment of depression.  
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Finally, in the remaining four studies, Ekkers et al. (2011) assessed competitive memory training 
(COMET) in the treatment of depression and rumination; Watkins, Baeyens, & Read (2009) 
compared concreteness training (CNT) against bogus CNT for the treatment of dysphoria; 
Watkins et al. (2012) compared guided self-help concreteness training against guided self-help 
relaxation training in the treatment of depression; and Wolitzky-Taylor & Telch (2010) compared 
worry exposure against expressive writing and Audio-photic stimulation (APS) for the reduction 
of academic and general worry in students. 
 
Treatment duration ranged from a single 90 minute session with testing immediately after the 
session (Feldman et al., 2010), to a maximum of 30 weeks of treatment (Leichsenring et al., 
2009); however, in the majority of studies (N=15) treatment varied from 4 weeks to 8 weeks. For 
most studies, treatment occurred on a weekly basis, either through online modules to be 
completed in the internet-based treatments or through face-to-face sessions with therapists 
either in group format or one-to-one format. Change in rumination and/or worry scores was 
assessed pre- and post-treatment in all studies, and 12 studies also reported follow-up data. 
Follow-up periods ranged from two months to three years; however, most studies followed up 
between three and six months post-treatment. Details of treatment duration and protocols can 
be reviewed in Table 2. 
 
[Insert Table 2 about here] 
 
MEDTHODOLOGICAL QUALITY AND TREATMENT INTEGRITY 
We scored studies for methodological quality according to criteria developed by Jadad et al. 
(1996); and for treatment integrity against items from Foa & Meadow’s “gold standards” for 
treatment outcome studies (Foa & Meadows, 1997). The 19 studies included in this review were 
assessed by both authors separately; and then together. Any disagreements were resolved by 
discussion between the authors. 
 
Methodological quality of included studies 
We assessed the included studies against three criteria from Jadad et al. (1996; participants 
randomised; study described as double blinded; and withdrawals/drop-outs described; see 
Table 3), and against one other criterion developed by the authors for this study (quality of 
statistical analysis). We’ve made our assessment of the following criteria based on the 
information provided in the published studies. 
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Participants randomised? 
According to Jadad et al. (1996): “A method to generate the sequence of randomization will be 
regarded as appropriate if it allowed each study participant to have the same chance of 
receiving each intervention and the investigators could not predict which treatment was next” 
(p.11). In this review, and in line with the guidelines from Jadad et al., if the study was described 
as randomised (which included the use of words such as randomly, random, and randomisation) 
we awarded the study one point. If the method of randomisation was described and it was 
appropriate (e.g., table of random numbers, computer generated, etc.) we gave the study an 
extra point; however, if the method of randomisation was described and it was inappropriate 
(e.g., methods of allocation using date of birth, date of admission, hospital numbers, or 
alternation), we deducted a point. The range of possible points for randomisation was 0-2.  
 
[Insert Table 3 about here] 
 
Eleven studies were awarded 2 points as their method of randomisation was well described and 
appropriate; two studies (Campbell et al., 2012; Feldman et al., 2010) received 0 points 
because they did not randomise participants; and six studies received 1 point for a number of 
reasons. Firstly, some of the studies stated that participants were randomised but did not 
provide detail on the randomisation process (Leichsenring et al., 2009; Robins et al., 2012; 
Vollestad et al., 2011; Watkins et al., 2009). These studies may have employed appropriate 
processes of randomisation but the lack of detail made it difficult for us to assess; and best 
practice suggests that randomisation processes should be reported in full. Secondly, one of the 
studies had a good randomisation process but then participants changed condition after 
randomisation had occurred (Shapiro et al., 2008); and finally, one study employed restricted 
randomisation (Steinmetz et al., 2012).  
 
Study described as double-blinded? 
According to Jadad et al. (1996) “a study must be regarded as double blind if the words “double 
blind” are used” (p. 11). Where studies used the words “double blind” we awarded one point. 
We then gave an additional point if the method of double blinding was described and it was 
appropriate; however, where the method of double blinding was described and it was not 
appropriate, we deducted a point. Therefore the range of possible scores for this criterion was 
0-2. None of the studies included in this review were described as double blinded and therefore 
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all received 0 as their score for this criterion. This does not reflect poorly on the designs of these 
studies. In reality, it is often very difficult to achieve double-blinding in studies in which 
participants are receiving psychological therapeutic interventions, especially when these 
interventions are delivered to participants in groups. 
 
Withdrawals / drop-outs described? 
According to Jadad et al. (1996) participants who were included in the study but did not 
complete treatment or who were not included in the analysis must be described. It is considered 
good practice to detail the number of withdrawals or drop-outs and to state the reasons for this. 
In order for a study to be awarded a point for this criterion, they must have included a statement 
with regards to withdrawals/drop-outs. Where a study has included no such detail they were not 
awarded a point. The range of possible points for this criterion is 0-1. Ten studies received 1 
point for this criterion. The remaining nine studies received 0 points as they did not include a 
statement with regards to reasons for participants withdrawing/dropping out.  
 
Quality of statistical analysis 
With regards to statistical analysis we were interested in the risk of introducing bias through the 
use of inappropriate techniques used when conducting intention-to-treat (ITT) analysis; or if the 
authors did not complete ITT analysis when a significant number of participants dropped out of 
treatment. In almost all randomised study designs, participants dropping out of treatment results 
in missing data. If there are only a few missing outcomes this will not be of major concern; 
however, when attrition rates are high, the method of dealing with missing data becomes 
important. Missing data is common and one review found that in approximately half of all RCTs 
outcomes were missing for more than 10% of participants (Wood, White, & Thompson, 2004). If 
authors decide to omit data for participants whose data is incomplete, instead only analysing 
“completers” of treatment, this approach loses power, and bias may be introduced (Altman, 
2009). Best practice dictates that ITT principles be adopted in all randomised trials. For 
example, the Consolidated Standards of Reporting Trials (CONSORT) statement for improving 
the quality of reports of RCTs states that all participants in each group should be analysed by 
“intention-to-treat” principles (Moher, Schulz, & Altman, 2001). In an ITT analysis all randomised 
participants are included in the analysis in their allocated groups, irrespective of treatment 
adherence or completion (Altman, 2009). 
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When we assessed the 19 studies in this review against this criterion, we evaluated the 
following points: Was ITT analysis performed?; If ITT analysis was not performed, was this 
appropriate (i.e., no drop-outs)?; If ITT analysis was performed, what was the method used for 
data imputation?; If ITT analysis was performed, were the results from both the ITT and 
‘completer’ samples reported? We also considered the attrition rate as studies with lower 
attrition rates would suffer less with regards to impact of data imputation. The majority of studies 
(N=15) stated that ITT analysis was performed. Out of the four studies which did not perform 
ITT analysis, in two studies (Feldman et al., 2010; Watkins et al., 2009), ITT analysis was not 
appropriate as the study design precluded attrition; however, the other two studies (Robins et 
al., 2010; Westra et al., 2009) only reported “completers” and this may have introduced 
significant bias in the results as the attrition rates were relatively high (26% and 18% 
respectively). Therefore, these studies may have overestimated the efficacy of treatment and 
the results should be viewed with caution.  
 
One of the main issues surrounding ITT analysis is how missing data is dealt with. One of the 
simplest and most commonly used method of imputing missing data is “last observation carried 
forward” (LOCF) analysis, in which missing final values of the outcome variable are replaced by 
the last known value before the participant was lost to follow-up. Even though this is a simple 
and easy method, there are strong grounds for not using it. LOCF assumes that the missing 
final value/s would be the same as the last recorded value/s; and this assumption is often 
implausible because dropping-out or withdrawing from treatment is likely to be associated with 
response to treatment (e.g., failure to respond; Altman, 2009). In studies of therapeutic or 
psychological treatments, often participants are assessed prior to treatment commencing, 
immediately after the end of treatment, and then they are followed up some time after treatment 
was finished (e.g., 6 months). If the last available observation is the pre-treatment observation 
(because the participant dropped out after randomisation but before treatment completion), 
there is obvious scope for the introduction of bias, especially when the participant attrition rate is 
high. Simple imputation methods (like LOCF) overestimate the reliability and precision of 
estimates, and the power of the study to assess the treatment. When data is missing, the 
sample size is reduced; however, simple imputation methods fail to take this into account and 
therefore tend to underestimate the variability of the results. There are other methods for 
imputing missing data (e.g., mixed model analyses; multiple imputation) which carry less risk of 
bias but these are more difficult to perform and thus, the LOCF method remains dominant. 
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In the studies in which ITT analysis was performed, nine studies (Campbell et al., 2012; Jain et 
al., 2007; Leichsenring et al., 2009; Robinson et al., 2010; Steinmetz et al., 2011; Titov et al., 
2010; Vollestad et al., 2011; Watkins et al., 2011; Watkins et al., 2012) employed the LOCF 
method for data imputation; and five of these studies (Campbell et al., 2012; Jain et al., 2007; 
Titov et al., 2010; Vollestad et al., 2011; Watkins et al., 2012) had an attrition rate of greater 
than 10 percent. However, Jain et al. (2007) and Vollestad et al. (2011) evidenced best practice 
by reporting results for both ‘completer’ and ITT samples providing assurance that the attrition 
rate did not compromise reported results; and Watkins et al. (2011) and Watkins et al. (2012) 
conducted sensitivity analysis to ensure that drop-outs did not adversely affect their results. 
Therefore, these four studies have mitigated the risk of using LOCF method. Campbell et al. 
(2012) and Titov et al. (2010) only reported ITT sample results and both had relatively high 
attrition rates (17% & 16% respectively); therefore their results may have been biased and 
should be viewed with caution. The remaining three studies using the LOCF method 
(Leichsenring et al., 2009; Robinson et al., 2010; Steinmetz et al., 2011) had relatively low 
attrition rates (8%, 7% and 5.5% respectively) therefore the risk of bias was quite low for these 
studies. 
 
The remaining six studies which performed ITT analysis were considered low risk in terms of 
introducing bias. Five studies employed methods for data imputation that are more robust than 
LOCF, e.g., mixed model analyses or multiple imputation (Andersson et al. 2012; Ekkers et al., 
2011; Paxling et al., 2011; Van Aalderen et al., 2012; Wolitzky-Taylor & Telch, 2010); and two of 
these studies further evidenced best practice by reporting both ‘completer’ and ITT sample 
results (Paxling et al., 2011; Wolitzky-Taylor & Telch, 2010). The remaining study (Shapiro et 
al., 2008) stated they performed ITT analysis but they did not clarify method of data imputation 
and they reported ITT results only; therefore, it was difficult to assess this study against this 
criterion. However, as they had a very low attrition rate (3%), the risk of bias was considered low 
for this study. 
 
[Insert Table 4 about here] 
 
Treatment integrity of included studies 
Treatment integrity of included studies was assessed against two criteria from Foa & Meadows 
(1997) gold standards for treatment integrity (valid and reliable measures; manualised, 
replicable, specific treatments) and a further criterion created for this study (intervention 
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delivered consistently). Table 4 shows a summary of level of risk of bias for each of these 
criteria for each of the included studies; and we expand on the summarised data in the text 
below. 
 
Foa & Meadows (1997) suggest the use of measures with good psychometric properties. 
Because this systematic review aimed to assess the efficacy of treatments in the reduction of 
rumination and/or worry, we assessed the validity and reliability of rumination and/or worry 
measures included. Only one study (Feldman et al., 2010) has been classified as potentially 
high in risk of bias as this study stated that they created their ‘repetitive thought’ and ‘reaction to 
repetitive thought’ items for the purposes of the study. This is not a statement about the veracity 
of the created items; it is purely a reflection that this measure has not been validated in any 
other studies so we cannot be sure of its validity or reliability. All other studies were considered 
low risk as they employed well validated and reliable measures. With regards to worry, all 
eleven studies measuring worry used the Penn State Worry Questionnaire (PSWQ; Meyer et 
al., 1990). Regarding rumination, five studies used the Response Styles Questionnaire (RSQ; 
Nolen-Hoeksema & Morrow, 1991); two studies used the Rumination-reflection questionnaire 
(RRQ; Trapnell & Campbell, 1999); one study used the Rumination on Sadness Scale (RSS; 
Raes, Hermans, & Eelen, 2003); one study used the Daily Emotion Report (DER; Nolen-
Hoeksema, Morrow & Fredrickson, 1993); and one study created their own items. 
 
Foa & Meadows (1997) suggest the use of treatment protocol manuals to ensure consistency 
and all studies in this review satisfied this standard. All of the studies in this review used 
manualised or proceduralised processes for treatment; therefore all are considered low risk. 
However, the use of manualised treatment protocols does not necessarily translate into 
consistent delivery of treatment. We considered factors such as whether or not treatments had 
been assessed for adherence to treatment manuals and experience of treatment providers. We 
also considered whether or not the quality of face-to-face treatments had been assessed 
independently. We classified all of the studies included in this review as ‘low risk’ of bias with 
regards to intervention delivery. Some of the studies had the advantage of absolute consistency 
as the intervention was delivered online; however, even those studies where the intervention 
was delivered face-to-face either to participants individually or in groups were considered low 
risk due to rigorous standards and quality assessment. 
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RESULTS 
The following results represent a narrative synthesis of all included studies. Given the 
heterogeneous nature of the studies included in this review (e.g., participants drawn from 
different populations and varied interventions delivered in different formats) it was not 
appropriate or feasible to conduct a meta-analysis. Petticrew & Gilbody (2004) suggest that 
studies with the best methodological quality should contribute more to the results of systematic 
reviews and this is the approach we adopted. Please see Table 5 for summarised results for the 
included studies. 
 
[Insert Table 5 about here] 
 
Effects of treatment on self-reported rumination 
Ten out of the 19 studies reported results regarding effect of treatment on rumination. Six of 
these studies utilised mindfulness-based or relaxation-focussed treatments delivered in group 
format in face-to-face sessions. Campbell et al. (2012), Robins et al. (2012), and Shapiro et al. 
(2008) employed mindfulness-based stress reduction (MBSR); while Van Aalderen et al. (2012) 
assessed mindfulness-based cognitive therapy (MBCT). In the other two studies, Feldman et al. 
(2010) assessed mindful-breathing (MB) against progressive muscle relaxation (PMR) or loving-
kindness-meditation (LKM); and Jain et al. (2007) assessed mindful-meditation (MM) against 
relaxation training (RT). 
 
Campbell et al. (2012) reported a significant reduction in rumination at the end of treatment for 
participants who had taken part in their eight-week MBSR programme when compared with 
participants in a waitlist control condition. However, this study did not randomise participants, 
and performed ITT analysis using LOCF with high attrition rates, therefore the results should be 
treated with caution. Robins et al. (2012) reported no significant reduction in rumination for 
participants in their eight week MBSR programme at the end of treatment; however, gains had 
been made by the MBSR over waitlist control group when participants were followed up two 
months post-treatment. As Robins et al. (2012) did not perform ITT analysis and only reported 
‘completers’ (with a high rate of attrition) these results must also be viewed with caution. 
Shapiro et al. (2008) compared participation in an eight-week MBSR programme against 
another meditation-based programme (EPP) and found that increases in mindfulness (in the 
MBSR group) mediated a significant reduction in rumination, and MBSR was considerably more 
effective than EPP in reducing rumination. Furthermore, participants who had taken part in the 
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MBSR programme showed further gains, through decreased levels of self-reported rumination, 
when followed-up two months after treatment. Randomisation was compromised in this study 
due to some participants changing condition after randomisation had been completed; however, 
this study was considered sound in other areas. Van Aalderen et al. (2012) reported that 
participants who had taken part in their eight-week MBCT programme reported significantly 
lower levels of rumination than participants in the waitlist control condition after treatment had 
ended.  
 
Feldman et al. (2010) assessed change in negative reaction to repetitive thoughts (rumination); 
and concluded that participants who took part in mindful-breathing (MB) reported a significantly 
greater reduction in negative reaction to repetitive thoughts than those in the progressive 
muscle relaxation (PMR) or loving-kindness-meditation (LKM) conditions. Interestingly, in this 
study participants in the MB condition reported a significantly greater increase in repetitive 
thoughts than participants in either the PMR or LKM conditions. Jain et al. (2007) assessed 
mindful-meditation (MM) against relaxation training (RT) and found that participants in the MM 
group reported significantly less ruminative and distractive thoughts than participants in either 
the RT or waitlist control groups (which were not significantly different to one another).  
 
The remaining four studies assessing change in self-reported rumination delivered their 
interventions via face-to-face format. Three of these studies were individual face-to-face 
treatment formats (Watkins et al., 2009; Watkins et al., 2011; and Watkins et al., 2012), whereas 
the final study delivered their training face-to-face in group format (Ekkers et al., 2011). Two 
studies (Watkins et al., 2009; Watkins et al., 2012) assessed concreteness training (CNT) which 
involves training individuals to be more concrete and specific in their thinking. In the study by 
Watkins et al. (2009), CNT was assessed against bogus CNT (BogusCNT = matched with CNT 
for treatment rationale, experimenter contact, and treatment duration but without the active 
“concrete thinking” component) for reduction of rumination in individuals with dysphoria (low 
mood). Participants attended an initial training session and then practiced the learned 
techniques for a period of seven days - with the support of audio CD exercises (CNT condition) 
or a website they could access (BogusCNT condition). After seven days, when participants were 
assessed, they found that participants in the CNT and BogusCNT groups reported significantly 
lower levels of self-reported rumination, when compared to participants in a waitlist control 
condition; and the two treatment groups were not significantly different to one another. In the 
other study, Watkins et al. (2012) assessed self-guided CNT (CNTself) against self-guided 
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relaxation training (RTself) in the treatment of depressed individuals. Participants in this study 
attended for an initial training session and then practiced at home over the course of six weeks 
with the support of exercises recorded on audio CD and detailed workbooks. They found that 
participants from the CNTself condition reported significantly lower levels of rumination than 
participants in either the RTself or waitlist control conditions. Furthermore, when the self-help 
response became habitual (at follow-up); participants in the CNTself group reported significantly 
lower levels of rumination than participants in the RTself group.  
 
Watkins et al. (2011) evaluated rumination-focussed CBT (RF-CBT) against a waitlist control 
condition in the treatment of depression. The duration of this treatment varied from 12 to 24 
weeks depending on client need and results showed that participants taking part in the RF-CBT 
programme reported significantly lower levels of rumination than those in the waitlist control 
condition after treatment was completed. Finally, Ekkers et al. (2011) considered the efficacy of 
competitive memory training (COMET) which is a seven-week cognitive behavioural 
intervention, involving weekly group sessions and homework, for the treatment of depression 
and rumination. COMET is designed to target underlying cognitive processes instead of the 
content of dysfunctional cognitions; therefore, its aim was to change the amount of involvement 
the patient has with their cognitions, rather than to change the negative emotions and thoughts 
themselves (Ekkers et al., 2011). They found that participants in the COMET condition reported 
significantly reduced levels of rumination when compared to the waitlist control group; and 27% 
of participants achieved a clinically significant reduction in rumination.  
 
Effects of treatment on self-reported worry 
Eleven out of the 19 included studies reported results with regards to change in self-reported 
worry. Six of these studies assessed treatments with a cognitive behaviour therapy (CBT) focus 
against either a waitlist control condition or other treatments (Andersson et al., 2012; 
Leichsenring et al., 2009; Paxling et al., 2011; Robins et al., 2012; Robinson et al., 2010; Titov 
et al., 2010; Westra et al., 2009). Out of these studies, four delivered their interventions via the 
Internet; while the other two studies delivered their interventions via individual face-to-face 
sessions (Leichsenring et al., 2009; Westra et al., 2009).  
 
Andersson et al. (2012) evaluated an eight-week Internet-based CBT (iCBT) programme 
against an eight-week Internet-based Psychodynamic therapy (iPDT) programme. They found 
that participants in both the iCBT and iPDT conditions reported significantly lower self-reported 
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worry than participants in a waitlist control group, and that there was no significant difference in 
treatment effectiveness between the Internet-delivered treatments. Furthermore, these 
differences were maintained at three month and 18 month follow-up. Paxling et al. (2011) and 
Titov et al. (2010) evaluated eight-week iCBT programmes against a waitlist control condition 
and found that worry was significantly reduced in those participants taking part in the iCBT 
programme in comparison to the waitlist control condition. Furthermore, these gains were 
maintained at follow-up: at three months (Titov et al., 2010), at 12 months and at three years 
(Paxling et al., 2011). However, results from the study by Titov et al. (2010) should be viewed 
with caution as the authors used the LOCF method in ITT analysis with a high attrition rate. 
Robinson et al. (2010) compared the efficacy of a six week Clinician-Assisted iCBT (CA-iCBT) 
programme to a six week Technician-Assisted iCBT (TA-iCBT) programme. They found that 
both treatments were equally effective at reducing worry when compared with the waitlist control 
group immediately post-treatment. Interestingly, at the three month follow-up, while the TA-iCBT 
had maintained treatment gains, the CA-iCBT group had made further gains.  
 
Leichsenring et al. (2009) compared CBT to psychodynamic psychotherapy (PDP) and 
assessed worry as a secondary measure. Participants in this study attended weekly or 
fortnightly sessions with a CBT or psychodynamic therapist for up to 30 weeks. They found that 
participants in the CBT group reported significantly lower levels of self-reported worry than 
participants in the PDP condition; and that treatment gains were maintained at six month follow-
up. In the study by Westra et al. (2009), the effect of adding motivational interviewing prior to 
CBT (MI-CBT) was assessed against CBT with no pre-treatment (NP-CBT). All participants 
attended an eight-week CBT programme conducted through individual face-to-face sessions 
with a CBT therapist; however, participants in the MI-CBT group additionally had 4 weekly 
sessions of motivational interviewing treatment prior to commencing their CBT programme. 
Results showed that participants in the MI-CBT reported significantly lower levels of self-
reported worry than those in the NP-CBT group. Interestingly, the authors reported that MI-CBT 
appeared most effective for participants with the highest worry scores at baseline; and whilst 
there was some evidence of relapse at six month follow-up, when participants were followed up 
at 12 months, treatment gains were again evident. However, this study reported results for 
‘completers’ only and had a relatively high attrition rate, therefore their findings may be inflated 
and the results should be viewed with caution. 
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Two of the remaining four studies (Robins et al., 2012; Vollestad et al., 2011) assessed eight-
week MBSR programmes, delivered via group face-to-face sessions, against waitlist control 
conditions. Both studies reported significant reduction in self-reported worry for participants from 
the MBSR group versus those in the waitlist control condition; furthermore, treatment gains were 
maintained at follow-up in both studies. However, the results from Robins et al. (2012) should 
be viewed with caution as they did not conduct ITT analysis in spite of the fact that they had a 
high rate of attrition (26%); and this may have resulted in an overestimation of treatment effect. 
Steinmetz et al. (2012) assessed the efficacy of a specialist website - My Disaster Recovery 
(MDR) - designed to help survivors of Hurricane Ike increase coping self-efficacy, against an 
information only (IO) website and waitlist control condition. The same information was 
essentially presented in both conditions; however, in the MDR site, participants enjoyed a more 
interactive experience (e.g., through self-tests and video vignettes). Participants were 
encouraged to access the sites as much as possible over a period of 30 days. After 30 days, 
results showed that participants in the MDR condition reported significantly reduced self-
reported worry that those participants accessing the IO website or in the waitlist control 
condition.  
 
In one of the remaining two studies, Van Aalderen et al. (2012) reported that participants who 
had taken part in their eight-week MBCT programme reported significantly lower levels of self-
reported worry than participants in the waitlist control condition after treatment had ended. The 
final study (Wolitzky-Taylor & Telch, 2010) evaluated worry exposure (WE), expressive writing 
(EW), and Audio-Photic Stimulation (APS) against a waitlist control condition for the reduction in 
self-reported academic and general worry. Audio-photic stimulation (APS) - also called Audio-
visual entrainment (AVE) - is a form of therapy used to promote relaxation and treat stress-
related disorders (Wolitzky-Taylor & Telch, 2010). In the current study APS was delivered via a 
device consisting of an iPod-sized control panel which connected into headphones emitting a 
programmable pulsing sound (similar to that of a beating heart) and sunglasses that emit 
programmable bursts of orange flickering light (Wolitzky-Taylor & Telch, 2010). All treatments 
comprised of an initial face-to-face training session and then self-practice over the course of 
four weeks. Results showed that WE and APS were significantly more effective than EW (which 
did not differ significantly from the waitlist control condition) at post-treatment. At follow-up 
(three months), all treatments had maintained gains; however, participants in the EW condition 
had made the most significant improvement with regards to reduction in worry, potentially 
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suggesting a delayed treatment effect. Summarised results for all included studies can be 
viewed in Table 5 (Appendix C). 
 
DISCUSSION 
This systematic review aimed to assess treatments utilised for the reduction of rumination 
and/or worry. Most of the studies included in the review evidenced fair to excellent 
methodological quality and treatment integrity. Nevertheless, there were a few studies for which 
we suggest results should be viewed with caution, predominantly due to the quality of statistical 
analysis. Robins et al. (2010) and Westra et al. (2009) did not conduct ITT analysis, choosing 
only to report findings from “completers” of treatment. In the context of significant attrition rates 
in these two studies (26% and 18% respectively), there is a risk that effect sizes have been 
overestimated. Campbell et al. (2012) and Titov et al. (2010) did conduct ITT analysis but chose 
to do so using the LOCF method for imputation of missing data. If their attrition rates had been 
low, the risk of bias would also be very low; however, their attrition rates were relatively high 
(17% and 16% respectively), therefore we also view their results with caution. Whilst LOCF is 
not the only method for the imputation of missing data, it is still the most widely used; however, 
given repeated warnings about the dangers of using the LOCF method it seems clear that its 
use as the sole form of analysis should be discontinued (Lane, 2008; Shapiro, 2001; Barnes, 
Mallinckrodt, Lindborg, & Carter, 2008; Streiner, 2002). 
 
Furthermore, the heterogeneous nature of the included studies may make generalisation 
difficult. For example, the studies included samples drawn from clinical, general adult and 
student populations; and employed various interventions delivered in different formats. This 
means that we could not compare effect sizes using meta-analyses as we may well expect the 
effect sizes of treatment, due to baseline differences in symptoms, and differences in ability to 
engage with treatment, to be quite different from each other. However, as our aim was to 
assess treatments used in the reduction of rumination and/or worry, and the majority of studies 
used the same well-validated measures for these constructs, we maintain they can be assessed 
against each other narratively. It is worth noting also that many of the studies included in this 
review reported substantially lower dropout rates than those reported in comparable studies in 
the clinical literature. For example, a recent meta-analysis reported average dropout rates of 
between 18% and 20% for psychodynamic or CBT-based treatments (Swift & Greenberg, 
2012). This may be reflective of the difference study populations included and may reflect a 
higher level of baseline functioning in the participants included in these studies. It may be that 
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some of the treatments which appear effective here may be less effective if participants were 
showing greater symptom severity at baseline. However, this is speculation and a detailed 
analysis of the difference in efficacy of treatment in different populations, whilst beyond the 
scope of this systematic review, presents an interesting avenue for future research.  
 
In spite of these limitations, this systematic review suggests that mindfulness-based and 
cognitive behavioural interventions may be useful in the treatment or reduction of both 
rumination and worry. Irrespective of delivery mode, both Internet-delivered and face-to-face 
delivered formats appear to be useful. However, it is worth noting that most of the Internet-
delivered interventions in this review were CBT-based interventions. Whether or not 
mindfulness-based interventions would be as effective if delivered via the Internet is worthy of 
further exploration. Treatments in which participants are encouraged to change their thinking 
style, or to disengage from emotional response to rumination or worry (e.g., through mindful 
techniques), may be helpful. For example, treatments which enable participants to adopt more 
concrete and specific thinking (Watkins et al., 2009; Watkins et al., 2012), or which cognitively 
restructure thinking in a more positive and constructive way (e.g., through CBT), appear to 
reduce rumination and worry. Perhaps interventions which require active mental engagement 
are useful because active mental engagement interferes with the more passive cognitive 
processes of rumination and/or worry? However, this is speculation and also requires further 
empirical work.  
 
Within the literature, worry, rumination, and many other cognitive processes (e.g., anticipatory 
stress; intrusive thoughts) are generally considered to be separate constructs, conceptually 
close but not equated with one another (Brosschot et al., 2006). This is not our position. We 
believe they are linked and are potentially underpinned by the same cognitive process, that of 
perseverative cognition (Brosschot et al., 2006). If this is the case, we would expect to see 
similar treatments proving effective for conditions for which worry and/or rumination are key 
components (e.g., depression and anxiety disorders). Findings from the studies included in this 
review may offer support for our position as similar formats of intervention appear to be helpful 
in reducing self-reported rumination and/or worry. There were two studies which measured the 
change in both rumination and worry (Robins et al., 2012; Van Aalderen et al., 2012) and in both 
of these studies rumination and worry were reduced by the same intervention. If rumination and 
worry represent different manifestations of perseverative cognition (Brosschot et al., 2006), it is 
possible that treatments are working by interfering with this process, thereby reducing both 
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rumination and worry; however, we do accept that there are also potentially other explanations 
for this and, as mentioned above, this provides an interesting avenue for future research. In 
addition, this review has not explored in detail the components of the included studies to reach 
an understanding of the specific shared mechanisms of the effective treatments; another 
avenue for future research. 
 
Interestingly, in the study by Feldman et al. (2010), the authors did not seek to reduce 
rumination; instead, the focus was on the reduction of negative evaluation of repetitive thoughts. 
Likewise, the study by Ekkers et al. (2011) aimed to reduce participants’ involvement with their 
cognitions, rather than to reduce cognitions in general or to change anything content-related. 
This suggests that rumination and/or worry per se may not be the issue but that an individual’s 
emotional response to the process of perseverative cognition may be more of a problem. This 
position is supported by a recent study in the occupational health literature which measured two 
distinct but related forms of work-related rumination – affective rumination and problem-solving 
pondering – in a large sample (N=719) of working adults (Querstret & Cropley, 2012). The 
authors suggested that affective rumination (characterised by negatively emotionally-valenced 
perseverative cognitions) would potentially be more detrimental than problem-solving pondering 
(characterised by perseverative cognitions without an emotional component) in the context of 
recovery from work-related demands (stressors). They found that affective rumination was 
significantly more predictive of both acute (short-term) and chronic (persistent; long-term) work-
related fatigue. The results of this study have been further bolstered by findings from a 
longitudinal follow-up which suggested affective rumination may be part of a causal model of 
work-related fatigue (Querstret & Cropley, in preparation). In line with the perseverative 
cognitions hypothesis (Brosschot et al., 2006), the authors posited that affective rumination may 
maintain psychophysiological arousal whereas problem-solving pondering may not. They have 
speculatively suggested that these different forms of work-related rumination may operate 
differentially in the brain with problem-solving pondering having a dampening effect (via the 
prefrontal cortex) of the emotional response. This raises an avenue worthy of future research. If 
rumination and/or worry per se are not as problematic as the individual’s emotional evaluation of 
these processes, perhaps interventions designed to change emotional interpretation would be 
just as effective as studies which aim to reduce rumination and/or worry. 
 
In the studies included in this review, the majority of CBT-based interventions were supported 
by trained clinicians; however, the results from Robinson et al. (2010) suggest that, in the short-
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term, iCBT may reduce worry when supported by non-clinicians. However, at follow-up those 
participants who had been managed by non-clinicians did not maintain gains in the same way 
as those who had support from trained therapists. This seems to suggest that a model for 
lasting treatment effect requires at least some training in the respective techniques for those 
delivering or supporting the respective interventions. In the context of improving access to 
psychological therapies, it would be advantageous to be able to develop and implement 
treatments that were effective without the need for expensive therapeutic support. This is an 
avenue worthy of future exploration.  
 
There is a possibility of publication bias in this review as the articles included all came from peer 
reviewed journals; and Petticrew & Roberts (2006) suggest it is more likely that the articles 
published would have concluded that the intervention was effective. Also, because the search 
for articles was limited to a specific time period (2002-2012), it is possible that contradictory 
results have been missed which could have added to this review. However, the objective of this 
review was to understand the current landscape with regards to available treatments. 
 
CONCLUSIONS 
This systematic review suggests that mindfulness-based and cognitive behavioural interventions 
may be effective in the reduction of both rumination and worry. Irrespective of delivery mode, 
both Internet-delivered and face-to-face delivered formats appear to be useful. More broadly, 
treatments in which participants are encouraged to change their thinking style, or to disengage 
from their emotional response to rumination and/or worry (e.g., through mindful techniques), 
could be helpful. 
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TABLE 1 
Details of included studies 
Study Country Study 
type 
Sample type Gender 
mix 
Sample 
size 
Attrition  
Rate (N) 
Andersson et al. (2012) Sweden RCT Clinical; GAD mixed N=81 7% (6) 
Campbell et al. (2012) Canada WLC Clinical; cancer patients female N=76 17% (13) 
Ekkers et al. (2011) Netherlands RCT Clinical; Dep; >65yrs mixed N=93 26% (24) 
Feldman et al. (2010) USA Rand Students female N=190 0% 
Jain et al. (2007) USA RCT Students mixed N=104 22% (23) 
Leichsenring et al. (2009) Germany Rand Clinical; GAD mixed N=57 8% (5) 
Paxling et al. (2011) Sweden RCT Gen Pop’n; GAD mixed N=89 8% (7) 
Robins et al. (2012) USA WLC Gen Pop’n mixed N=56 26% (15) 
Robinson et al. (2010) Australia RCT Gen Pop’n; GAD mixed N=150 7% (12) 
Shapiro et al. (2008) USA RCT Students mixed N=47  6% (3) 
Steinmetz et al. (2012) USA RCT Hurricane Ike survivors mixed N=56 5.5%(10) 
Titov et al. (2010) Australia RCT Gen Pop’n; GAD; PD; 
SP 
mixed N=86 16% (14) 
Van Aalderen et al. (2012) Netherlands RCT Clinical; Dep mixed N=205 6% (14) 
Vollestad et al. (2011) Norway RCT Gen Pop’n; GAD; PD; 
SAD 
mixed N=76 14% (11) 
Watkins et al. (2009) England RCT Gen Pop’n; Dys mixed N=60 0% (0) 
Watkins et al. (2011) England RCT Clinical; Dep mixed N=42  9.5% (4) 
Watkins et al. (2012) England RCT Clinical; Dep mixed N=121 15% (18) 
Westra et al. (2009) Canada RCT Gen Pop’n; GAD mixed N=76 18% (14) 
Wolitzky-Taylor & Telch 
(2010) 
USA RCT Students; academic 
worry 
mixed N=113 26% (29) 
Study type: RCT=Randomised Controlled Trial; WLC=Waitlist Controlled Trial; Rand=multiple randomised 
treatment groups, no control group. Sample type: GAD=Generalised Anxiety Disorder diagnosis; PD=Panic 
Disorder diagnosis; SP=Social Phobia diagnosis; SAD=Social Anxiety Disorder diagnosis; Dys=dysphoria (sub-
clinical low mood); Dep=Depression diagnosis; clinical=participants recruited from clinical environment (e.g. 
hospital; GP practice); Gen Pop’n=recruited from general population 
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TABLE 2 
Study designs and treatment protocols of included studies 
Study Study 
type 
Study 
groups 
Treatment 
mode 
Treatment protocol Measure Treatment 
duration 
Follow-
up 
Andersson et al. (2012) RCT iCBT vs. 
iPDT vs.  
WC 
Internet iCBT: 8 x weekly online sessions + weekly homework + 
feedback (via email) from therapist 
iPDT: 8 x weekly online sessions + support & guidance 
from therapist (via email) 
PSWQ 
(worry) 
8 weeks 3 & 
18mth 
Campbell et al. (2012) WLC MBSR vs.  
WC 
F2F Group MBSR: 8 x weekly group sessions (90mins/ session) + 6hr 
workshop (b/t weeks 6&7) + daily home practice of 
mindfulness techniques (45mins/day) 
RRQ 
(rumination) 
8 weeks Nonea 
Ekkers et al. (2011) RCT COMET+TAU 
vs. TAU 
F2F Group COMET: 7 x group sessions + daily homework 
assignments; TAU: psycho-pharmacology (medication + 
therapeutic support ) 
RSQ; RSS 
(rumination) 
7 weeks Nonea 
Feldman et al. (2010) Rand MB vs.  
PMR vs.  
LKM 
F2F Group One session; 15 minutes instruction in relevant technique, 
then own practice 
Freq Rep 
thought & Neg 
reaction to 
Rep thought 
(rumination) 
1 session Nonea 
Jain et al. (2007) RCT MM vs.  
RT vs.  
WC 
F2F Group MM & RT: 4 x weekly group sessions (90mins/session) + 
one 6hr Saturday retreat b/t weeks 3 & 4 + tapes, manuals 
and homework assignments + weekly questionnaires + 
weekly practice logs 
DER 
 
4 weeks Nonea 
Leichsenring et al. 
(2009) 
RCT CBT vs.  
PDP 
F2F Up to 30 x weekly sessions (50mins/session) PSWQ 30 weeks 6mth 
Paxling et al. (2011) RCT iCBT vs.  
WC 
Internet iCBT: 8 x weekly modules (text & images) + weekly 
homework assignments + weekly feedback from therapist 
and reminder emails 
PSWQ 8 weeks 12mth & 
3yr 
Robins et al. (2012) WLC MBSR vs.  
WC 
F2F Group 8 x weekly face-to-face group sessions (2.5 hours); plus 45 
mins/day (6 days/week) own practice at home 
RSQ; PSWQ 
(rumination 
and worry) 
8 weeks 2mth 
Robinson et al. (2010) RCT TA-iCBT vs. 
CA-iCBT vs. 
WC 
Internet Both treatments: 6 x weekly online lessons + weekly 
homework (to be completed in 10 weeks); TA group 
assisted by non-clinician via email & telephone; CA group 
assisted by clinician via email, telephone and web forum 
PSWQ 
(worry) 
6 weeks 3mth 
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Shapiro et al. (2008) RCT MBSR vs. 
EPP vs.  
WC 
F2F Group MBSR & EPP: 8 x weekly face-to-face group sessions 
(90mins/ session) + daily at home practice of learned 
techniques 
RRQ 
(rumination) 
8 weeks 2mth 
Steinmetz et al. (2012) Pilot 
RCT 
MDR vs.  
IO vs.  
TAU 
Internet Participants instructed to access website as much as 
possible over the course of a month (30 days) 
PSWQ 
(worry) 
30 days Nonea 
Titov et al. (2010) RCT iCBT vs.  
WC 
Internet ICBT: 6 x weekly lessons online + weekly homework (to be 
completed within 8 weeks) +support from therapist 
PSWQ 
(worry) 
8 weeks 3mthb 
Van Aalderen et al. 
(2012) 
RCT MBCT+TAU 
vs. TAU 
F2F Group MBCT: 8 x weekly group sessions (2.5hrs/session) + one 
silent day/week (6 hours meditation); +45 mins/day own 
MBCT practice (with CDs to support practice) 
RSS; PSWQ 
(rumination 
and worry) 
8 weeks 3mth 
Vollestad et al. (2011) RCT MBSR vs.  
WC 
F2F Group MBSR: 8 x weekly group sessions (2.5hr/session) + half 
day meditation retreat (after class 6) + daily home practice 
with audio CDs + daily record keeping of mindfulness 
exercises 
PSWQ 
(worry) 
8 weeks 6mth 
Watkins et al. (2009) RCT CNT vs. 
BogusCNT vs. 
WC 
F2F Trainc Both treatment groups: Initial session (1.5-2hr) for training; 
then 7 days self-practice (CNT: audio; BGT: website); post-
treatment assessment ASAP after treatment 
RSQ 
(rumination) 
7 days Nonea 
Watkins et al. (2011) RCT RF-CBT+TAU 
vs. TAU 
F2F RF-CBT: Manualised rumination-focussed CBT treatment; 
up to 12 individual face-to-face sessions (either weekly or 
fortnightly) 
RSQ 
(rumination) 
12-24 
weeks 
Nonea 
Watkins et al. (2012) RCT CNTself+TAU 
vs. 
RTself+TAU 
vs. TAU 
F2F Train Both treatment groups: initial F2F session (1.5hrs) + 
patient self-practice using exercises recorded on 
audiotape/CD supported by detailed workbook 
RSQ 
(rumination) 
6 weeks 3 & 
6mth  
Westra et al. (2009) RCT MI-CBT vs. 
NP-CBT 
F2F MI-CBT: 4 weeks MI (one MI session/ week, 50 
mins/session) + CBT (8 weeks; 6x2hr sessions, then 2x1hr 
sessions); NP-CBT: CBT as above 
PSWQ 
(worry) 
8-12 
weeks 
6 & 
12mth 
Wolitzky-Taylor & Telch 
(2010) 
RCT WE vs. EW 
vs. APS vs. 
WLC 
F2F Train WE: training session (30-45mins), then home practice 20-
30mins/session; EW: first session in lab (20mins), then 
home practice 20mins/session; APS: training session 
(35mins), then home practice 35mins/session (all home 
practice = minimum 3x/week for a month) 
AWQ; PSWQ 
(worry) 
4 weeks 3mth 
Study type: RCT=Randomised Controlled Trial; WLC=Waitlist Controlled Trial; Rand=multiple randomised treatment groups, no control group. Study groups: iCBT=Internet-
based Cognitive Behavioural Therapy; iPDT=Internet-based Psycho-dynamic treatment; MBSR= Mindfulness-Based Stress Reduction; COMET=COmpetitive MEmory 
Training; MB=Mindful breathing; PMR=Progressive muscle relaxation; LKM=Loving-kindness meditation;  MM=Mindfulness Meditation; RT=Relaxation Training;  
 40 
 
 
 
CBT=Cognitive Behaviour Therapy; PDP=Psychodynamic Psychotherapy; TA-iCBT=Technician-Assisted Cognitive Behavioural Therapy; CA-iCBT=Clinician-Assisted 
Cognitive Behavioural Therapy; EPP= Easwaran’s Eight-Point Program; MDR=My Disaster Recovery website; IO=Information Only website; MBCT=Mindfulness-Based 
Cognitive Therapy; CNT=Concreteness Training; BogusCNT=Bogus Concreteness Training; RF-CBT=Rumination-Focussed Cognitive Behavioural Therapy; CNTself=Self-
help concreteness training; RTself=Self-help relaxation training; MI-CBT=Motivational Interviewing pre-treatment + CBT; NP-CBT=No pre-treatment + CBT; WE=Worry 
exposure; EW=Expressive Writing; APS=Audio-Photic Stimulation; WC=Waitlist Control; TAU=Treatment As Usual. Treatment mode:  F2F=Face-to-face individual therapy; 
F2F Group=Group therapy face-to-face; F2F Train=F2F training + own practice; Internet=intervention online. Rumination/worry measure: PSWQ=Penn State Worry 
Questionnaire; RRQ=Rumination-Reflection Questionnaire; RSQ=Response Styles Questionnaire; RSS=Rumination on Sadness Scale;  Freq Rep thought & Neg reaction 
Rep thought=Frequency of repetitive thoughts & Negative reaction to repetitive thoughts, measured via items created for the study; DER=Daily Emotion Report; 
AWQ=Academic Worry Questionnaire. aParticipants assessed pre-treatment and post-treatment only. bTreatment group only. cTraining is face-to-face, then intervention for 
CNT=web-based & intervention for BogusCNT=audio. 
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TABLE 3 
Methodological quality of included studies 
Study name Participants 
randomised?  
(0-2) 
Study described as 
double-blinded?  
(0-2) 
Withdrawals/drop-
outs described? 
(0-1)  
Total 
score 
(0-5) 
Andersson et al. (2012) 2 0b 0c 2 
Campbell et al. (2012) 0a 0b 1 1 
Ekkers et al. (2011) 2 0b 1 3 
Feldman et al. (2010) 0a 0b 0 0 
Jain et al. (2007) 2 0b 1 3 
Leichsenring et al. (2009) 1d 0b 1 2 
Paxling et al. (2011) 2 0b 1 3 
Robins et al. (2012) 1d 0b 0c 1 
Robinson et al. (2010) 2 0b 0c 2 
Shapiro et al. (2008) 1e 0b 1 2 
Steinmetz et al. (2012) 1f 0b 0c 1 
Titov et al. (2010) 2 0b 0 2 
Van Aalderen et al. (2012) 2 0b 1 3 
Vollestad et al. (2011) 1d 0b 1 2 
Watkins et al. (2009) 1d 0b 0c 1 
Watkins et al. (2011) 2 0b 1 3 
Watkins et al. (2012) 2 0b 1 3 
Westra et al. (2009) 2 0b 0c 2 
Wolitzky-Taylor & Telch (2010) 2 0b 0c 2 
Higher scores = better study quality; aNo randomisation or method  of randomisation not appropriate; bNot 
described as double blinded; cNo description of reasons for participants dropping out or withdrawing; dStudy 
states participants randomly allocated to groups but provides no detail on process; eGood randomisation 
process but participants allowed to change groups after randomisation due to schedule clashes; fRestricted 
randomisation 
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TABLE 4 
Assessment of treatment integrity in included studies 
Study name Valid and reliable 
measures?* 
Manualised, replicable, 
specific treatments?* 
Intervention delivered 
consistently?# 
Andersson et al. (2012) Low Low Low 
Campbell et al. (2012) Low Low Low 
Ekkers et al. (2011) Low Low Low 
Feldman et al. (2010) Higha Low Low 
Jain et al. (2007) Low Low Low 
Leichsenring et al. (2009) Low Low Low 
Paxling et al. (2011) Low Low Low 
Robins et al. (2012) Low Low Low 
Robinson et al. (2010) Low Low Low 
Shapiro et al. (2008) Low Low Low 
Steinmetz et al. (2012) Low Low Low 
Titov et al. (2010) Low Low Low 
Van Aalderen et al. (2012) Low Low Low 
Vollestad et al. (2011) Low Low Low 
Watkins et al. (2009) Low Low Low 
Watkins et al. (2011) Low Low Low 
Watkins et al. (2012) Low Low Low 
Westra et al. (2009) Low Low Low 
Wolitzky-Taylor & Telch (2010) Low Low Low 
*Based on Foa & Matthews’ (1997) “gold standards” for treatment outcome trials; #criteria added for this 
systematic review; Low=low risk of bias; Unclear= insufficient detail to evaluate risk; High=high risk of bias; 
n/a=not applicable to this study design; aItems created by the authors for this study so not validated or 
reliable 
 43 
 
TABLE 5 
Summarised results of all included studies 
Study Study Groups Follow-up? Rumination/worry findings 
Andersson et 
al. (2012) 
iCBT vs. iPDT 
vs. WC 
3mth &  
18mth 
Worry: post-treatment - significant reduction in worry for both 
treatment groups in comparison to control (no significant 
difference between ICBT and IPDT groups); at 3mth & 18mth 
follow-up – same as post-treatment 
Campbell et 
al. (2012) 
MBSR vs. WC None Rumination: MBSR group reported significantly lower levels of 
rumination than WLC group 
Ekkers et al. 
(2011) 
 
COMET+TAU 
vs. TAU 
None Rumination: Patients in TAU+COMET condition reported 
significantly reduced rumination when compared with control 
group for both rumination measures; 27% of patients achieved 
clinically significant reduction in rumination 
Feldman et 
al. (2010) 
MB vs. PMR 
vs. LKM 
None Repetitive thought: Negative reaction to repetitive thoughts 
was reduced in the MB condition relative to the other two 
conditions; increased frequency of repetitive thoughts in the 
MB vs. other two conditions; however, decreased levels of 
negative reaction to repetitive thoughts in MB condition 
Jain et al. 
(2007) 
MM vs. RT vs. 
WC 
None Rumination and distraction: Participants in the MM group 
showed significantly greater reduction in ruminative and 
distractive thoughts to those in the RT and control groups, 
which were not significantly different to each other 
Leichsenring 
et al. (2009) 
PDP vs. CBT 6mths  Worry: CBT significantly more effective than psychodynamic 
psychotherapy at reducing symptoms of worry; treatment 
effects maintained at 6 mth follow-up 
Paxling et al. 
(2011) 
iCBT vs. WC 12mth &  
3 years 
Worry: significantly reduced for those in the guided Internet-
delivered CBT condition vs. WLC; treatment effects 
maintained at 1yr and 3yr follow-up 
Robins et al. 
(2012) 
MBSR vs. WC 2mths Rumination: no significant difference for MBSR group from 
pre- to post-treatment; however, significant difference 
between pre-treatment and follow-up as MBSR and waitlist 
groups combined (after WL group completed MBSR training)  
Worry: significant reduction from pre- to post-treatment and at 
follow-up for MBSR group in comparison to WC group 
Robinson et 
al. (2010) 
CA-iCBT vs. 
TA-iCBT vs. 
WC 
3mths Worry: At post-treatment both treatment groups equally 
efficacious at reducing worry symptoms – no change in WLC 
group; At 3mth follow-up TA assisted group has maintained 
treatment gains, CA assisted group has made further gains 
Shapiro et al. 
(2008) 
 
MBSR vs. EPP 
vs. WC 
2mths 
 
Rumination: Increases in mindfulness mediated a significant 
reduction in rumination in the MBSR group, but not in EPP 
participants, when compared with WC participants; follow-up 
data not reported 
Steinmetz et 
al. (2012) 
MDR vs. IO vs. 
usual care 
(control) 
None  
 
Worry: MDR website significantly better at reducing self-
reported worry than information only or usual care 
Titov et al. 
(2010) 
iCBT vs. WC 3mths 
(treatment 
group only) 
Worry: Significant reduction in worry for ICBT group from pre-
treatment to post-treatment and from pre-treatment to follow-
up 
Van Aalderen 
et al. (2012) 
MBCT+TAU 
vs. TAU 
3mths 
 
Rumination and worry: MBCT+TAU group significantly 
reduced levels of rumination and worry than TAU group; 
maintained at follow-up 
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Vollestad et 
al. (2011) 
MBSR vs. WC 6mths Worry: significant reduction in self-reported worry for those in 
MBSR condition vs. WLC; treatment gains maintained at 6mth 
follow-up 
Watkins et al. 
(2009) 
CNT vs. 
BogusCNT vs. 
WC 
None Rumination: significantly reduced rumination in the CNT & 
BogusCNT conditions vs. WLC; however, there was no 
significant difference between CNT & BogusCNT groups 
Watkins et al. 
(2011) 
RF-CBT vs. 
WC 
None Rumination: Participants in the RFCBT group significantly 
lower levels of self-reported rumination at post-treatment 
when compared with those in WLC 
Watkins et al. 
(2012) 
TAU (control) 
vs. 
TAU+CNTself 
vs. 
TAU+RTself  
3mths & 
6mths 
Rumination: at post-treatment TAU+CNTself resulted in 
significantly reduced levels of self-reported rumination than 
TAU or TAU+RTself; TAU+CNTself was significantly more 
effective than TAU+RTself when self-help response became 
habitual 
Westra et al. 
(2009) 
MI-CBT vs. 
NP-CBT  
6mths & 
12mths  
Worry: MI-CBT group showed significantly greater reduction in 
worry than CBT alone (NP-CBT) 
Wolitzky-
Taylor & 
Telch (2010) 
 
WE vs. EW vs. 
APS vs. WC 
3mths Academic worry & General worry: WE and APS were 
significantly more effective than EW which did not differ 
significantly from WLC post-treatment. At follow-up, all 
treatments maintained gains; however, EW made the most 
significant gain 
Study groups: iCBT=Internet-based Cognitive Behaviour Therapy; iPDT=Internet-based Psycho-dynamic treatment; 
MBSR= Mindfulness-Based Stress Reduction; COMET=COmpetitive MEmory Training; MB=Mindful breathing; 
PMR=Progressive muscle relaxation; LKM=Loving-kindness meditation;  MM=Mindfulness Meditation; RT=Relaxation 
Training;  CBT=Cognitive Behaviour Therapy; PDP=Psychodynamic Psychotherapy; TA-iCBT=Technician-Assisted 
iCBT; CA-iCBT=Clinician-Assisted iCBT; EPP= Easwaran’s Eight-Point Program; MDR=My Disaster Recovery 
website; IO=Information Only website; MBCT=Mindfulness-Based Cognitive Therapy; CNT=Concreteness Training; 
BogusCNT=Bogus Concreteness Training; RF-CBT=Rumination-Focussed Cognitive Behavioural Therapy; 
CNTself=Self-help concreteness training; RTself=Self-help relaxation training; MI-CBT=Motivational Interviewing pre-
treatment + CBT; NP-CBT=No pre-treatment + CBT; WE=Worry exposure; EW=Expressive Writing; APS=Audio-
Photic Stimulation; WC=Waitlist Control; TAU=Treatment As Usual 
 
 
 
 
 
 
